| ASSET | YEAR | % RETURN |
|---|---|---|
ADMA Biologics (ADMA) | 2013 | 11.43% |
ADMA Biologics (ADMA) | 2014 | 43.21% |
ADMA Biologics (ADMA) | 2015 | -28.27% |
ADMA Biologics (ADMA) | 2016 | -36% |
ADMA Biologics (ADMA) | 2017 | -37.43% |
ADMA Biologics (ADMA) | 2018 | -25.78% |
ADMA Biologics (ADMA) | 2019 | 68.07% |
ADMA Biologics (ADMA) | 2020 | -51.73% |
ADMA Biologics (ADMA) | 2021 | -30.2% |
ADMA Biologics (ADMA) | 2022 | 177.14% |
ADMA Biologics (ADMA) | 2023 | 14.72% |
ADMA Biologics (ADMA) | 2024 | 281.11% |
ADMA Biologics (ADMA) | 2025 | 5.25% |
ADMA Biologics (ADMA) | 2026 | -49.97% |
